The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Conte Lisa A | See Remarks, Director | Grant(A) | 29K | — | $0 |
| Dec 11, 2025 | Conte Lisa A | See Remarks, Director | Grant(A) | 29K | — | $0 |
| Dec 11, 2025 | Wolin Jonathan S. | See Remarks | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | Wolin Jonathan S. | See Remarks | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | King Steven R. | See Remarks | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | King Steven R. | See Remarks | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | Micek John | Director | Grant(A) | 7K | — | $0 |
| Dec 11, 2025 | Micek John | Director | Grant(A) | 7K | — | $0 |
| Dec 11, 2025 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | Jayasuriya Anula | Director | Grant(A) | 6K | — | $0 |
| Dec 11, 2025 | Jayasuriya Anula | Director | Grant(A) | 6K | — | $0 |
| Dec 11, 2025 | Siegel Jonathan B. | Director | Grant(A) | 7K | — | $0 |
| Dec 11, 2025 | Siegel Jonathan B. | Director | Grant(A) | 7K | — | $0 |
| Dec 11, 2025 | Bochnowski James J | Director | Grant(A) | 6K | — | $0 |
| Dec 11, 2025 | Bochnowski James J | Director | Grant(A) | 6K | — | $0 |
| Dec 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 12K | — | $0 |
| Dec 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 12K | — | $0 |
| Jun 24, 2025 | Conte Lisa A | CEO and President, Director | Disposed to issuer(D) | 9K | $50,000.00 | $450.0M |
| Jun 24, 2025 | Conte Lisa A | CEO and President, Director | Grant(A) | 9K | $50,000.00 | $473.1M |
| Jun 24, 2025 | Conte Lisa A | CEO and President, Director | Grant(A) | 18K | — | — |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | Grant(A) | 9K | $50,000.00 | $473.1M |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | Disposed to issuer(D) | 9K | $50,000.00 | $450.0M |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | Grant(A) | 18K | — | — |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Disposed to issuer(D) | 4K | $20,000.00 | $72.0M |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 7K | — | — |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 4K | $20,000.00 | $75.7M |
| Jun 24, 2025 | King Steven R. | See Remarks | Grant(A) | 4K | $20.00 | $76K |
| Jun 24, 2025 | King Steven R. | See Remarks | Grant(A) | 7K | — | — |
| Jun 24, 2025 | King Steven R. | See Remarks | Disposed to issuer(D) | 4K | $20,000.00 | $72.0M |
| Jun 24, 2025 | Bochnowski James J | Director | Grant(A) | 55K | — | — |
| Jun 24, 2025 | Bochnowski James J | Director | Disposed to issuer(D) | 27K | $150,000.00 | $4.1B |
| Jun 24, 2025 | Bochnowski James J | Director | Grant(A) | 28K | $150,000.00 | $4.3B |
| Jun 24, 2025 | Micek John | Director | Grant(A) | 18K | — | — |
| Jun 24, 2025 | Micek John | Director | Disposed to issuer(D) | 9K | $50,000.00 | $450.0M |
| Jun 24, 2025 | Micek John | Director | Grant(A) | 9K | $50,000.00 | $473.1M |
| Jun 24, 2025 | Siegel Jonathan B. | Director | Disposed to issuer(D) | 9K | $50,000.00 | $450.0M |
| Jun 24, 2025 | Siegel Jonathan B. | Director | Grant(A) | 18K | — | — |
| Jun 24, 2025 | Siegel Jonathan B. | Director | Grant(A) | 9K | $50,000.00 | $473.1M |
| May 17, 2025 | Conte Lisa A | CEO and President, Director | Option exercise(M) | 2 | — | — |
| May 17, 2025 | Conte Lisa A | CEO and President, Director | Option exercise(M) | 2 | — | $0 |
| May 17, 2025 | King Steven R. | See Remarks | Option exercise(M) | 1 | — | — |
| May 17, 2025 | King Steven R. | See Remarks | Option exercise(M) | 1 | — | $0 |
| Mar 31, 2025 | Lizak Carol R. | Chief Financial Officer | Buy(P) | 5K | $30,000.00 | $162.0M |
| Mar 31, 2025 | Lizak Carol R. | Chief Financial Officer | Buy(P) | 5K | — | — |
| Mar 31, 2025 | Wolin Jonathan S. | See Remarks | Buy(P) | 9K | $50,000.00 | $450.0M |
| Mar 31, 2025 | Wolin Jonathan S. | See Remarks | Buy(P) | 9K | — | — |
| Mar 31, 2025 | Bochnowski James J | Director | Buy(P) | 27K | $150,000.00 | $4.1B |
| Mar 31, 2025 | Bochnowski James J | Director | Buy(P) | 27K | — | — |
| Mar 31, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Buy(P) | 4K | — | — |
| Mar 31, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | Buy(P) | 4K | $20,000.00 | $72.0M |
| Mar 31, 2025 | Conte Lisa A | CEO and President, Director | Buy(P) | 9K | — | — |
| Mar 31, 2025 | Conte Lisa A | CEO and President, Director | Buy(P) | 9K | $50,000.00 | $450.0M |
| Mar 31, 2025 | Siegel Jonathan B. | Director | Buy(P) | 9K | $50,000.00 | $450.0M |
| Mar 31, 2025 | Siegel Jonathan B. | Director | Buy(P) | 9K | — | — |
| Mar 31, 2025 | King Steven R. | See Remarks | Buy(P) | 4K | — | — |
| Mar 31, 2025 | King Steven R. | See Remarks | Buy(P) | 4K | $20,000.00 | $72.0M |
| Mar 31, 2025 | Micek John | Director | Buy(P) | 9K | $50,000.00 | $450.0M |
| Mar 31, 2025 | Micek John | Director | Buy(P) | 9K | — | — |
| Oct 8, 2024 | Siegel Jonathan B. | Director | Grant(A) | 27K | — | $0 |
| Oct 8, 2024 | King Steven R. | See Remarks | Grant(A) | 5K | — | $0 |
| Oct 8, 2024 | King Steven R. | See Remarks | Grant(A) | 39K | — | $0 |
| Oct 8, 2024 | Jayasuriya Anula | Director | Grant(A) | 21K | — | $0 |
| Oct 8, 2024 | Bochnowski James J | Director | Grant(A) | 23K | — | $0 |
| Oct 8, 2024 | Micek John | Director | Grant(A) | 27K | — | $0 |
| Oct 8, 2024 | Conte Lisa A | See Remarks, Director | Grant(A) | 17K | — | $0 |
| Oct 8, 2024 | Conte Lisa A | See Remarks, Director | Grant(A) | 132K | — | $0 |
| Oct 8, 2024 | Wolin Jonathan S. | See Remarks | Grant(A) | 5K | — | $0 |
| Oct 8, 2024 | Wolin Jonathan S. | See Remarks | Grant(A) | 39K | — | $0 |
| Oct 8, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 5K | — | $0 |
| Oct 8, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 39K | — | $0 |
| Oct 8, 2024 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 4K | — | $0 |
| Oct 8, 2024 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 34K | — | $0 |
| May 17, 2024 | Conte Lisa A | CEO and President, Director | Option exercise(M) | 3K | — | — |
| May 17, 2024 | Conte Lisa A | CEO and President, Director | Option exercise(M) | 3K | — | $0 |
| May 17, 2024 | King Steven R. | See Remarks | Option exercise(M) | 612 | — | — |
| May 17, 2024 | King Steven R. | See Remarks | Option exercise(M) | 612 | — | $0 |
| May 17, 2024 | Lizak Carol R. | Chief Financial Officer | Option exercise(M) | 431 | — | — |
| May 17, 2024 | Lizak Carol R. | Chief Financial Officer | Option exercise(M) | 431 | — | $0 |
| May 17, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | Option exercise(M) | 871 | — | — |
| May 17, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | Option exercise(M) | 871 | — | $0 |
| May 17, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Option exercise(M) | 871 | — | — |
| May 17, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Option exercise(M) | 871 | — | $0 |
| Apr 5, 2024 | Conte Lisa A | CEO and President, Director | Option exercise(M) | 600 | — | — |
| Apr 5, 2024 | Conte Lisa A | CEO and President, Director | Grant(A) | 600 | — | $0 |
| Apr 5, 2024 | King Steven R. | See Remarks | Option exercise(M) | 178 | — | — |
| Apr 5, 2024 | King Steven R. | See Remarks | Grant(A) | 178 | — | $0 |
| Apr 5, 2024 | Lizak Carol R. | Chief Financial Officer | Option exercise(M) | 60 | — | — |
| Apr 5, 2024 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 60 | — | $0 |
| Apr 5, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | Option exercise(M) | 89 | — | — |
| Apr 5, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | Grant(A) | 89 | — | $0 |
| Apr 5, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Option exercise(M) | 134 | — | — |
| Apr 5, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 134 | — | $0 |
| Aug 14, 2023 | Conte Lisa A | CEO and President, Director | Grant(A) | 384K | — | $0 |
| Aug 14, 2023 | King Steven R. | see remarks | Grant(A) | 159K | — | $0 |
| Aug 14, 2023 | Lizak Carol R. | Chief Financial Officer | Grant(A) | 142K | — | $0 |
| Aug 14, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | Grant(A) | 197K | — | $0 |
| Aug 14, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | Grant(A) | 204K | — | $0 |
| Aug 14, 2023 | Bochnowski James J | Director | Grant(A) | 77K | — | $0 |
| Aug 14, 2023 | Micek John | Director | Grant(A) | 69K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).